Eleni Andreopoulou

Weill Cornell Medicine, Division of Hematology and Medical Oncology, Weill Cornell Breast Center, New York, NY, US
Dr Eleni Andreopoulou is an Associate Professor of Medicine and the Director of Breast Cancer Clinical Research at Weill Cornell Medicine and New York-Presbyterian Hospital, New York, NY, US, where she specializes in the care and treatment of patients with breast cancer. She is also a member of the Englander Institute for Precision Medicine at Cornell. She previously held faculty positions at the Albert Einstein College of Medicine and Montefiore Medical Center, New York, and the University of Texas MD Anderson Cancer Center, Houston, Texas, US. Dr Andreopoulou completed her training in major academic institutions in both Europe and the US, including St Bartholomew’s Hospital and the Royal Marsden Hospital and Institute of Cancer Research in London, UK, and the New York University School of Medicine. She was a European Society of Medical Oncology fellow and was also awarded the Calabresi Scholarship in mentored cancer therapeutics. Dr Andreopoulou has a special interest in the individualization of patient treatment, particularly in caring for women with aggressive breast cancer. Her main research interest involves precision medicine to fast-track the drug development of biologics and targeted therapy to effectively manage, treat and cure breast cancer. She is involved with all phases of clinical drug development and especially focuses on innovative preoperative clinical trial design that incorporates cutting-edge technology. Dr Andreopoulou’s research involves projects focused on pharmacogenomics predictors of response to treatment for early and advanced stage breast cancer. Dr Andreopoulou is an active investigator of several clinical trials of novel therapeutic approaches in advanced disease, including her leadership role as a principal investigator in the development of drugs sponsored by the Cancer Therapy Evaluation Program at the National Cancer Institute. Dr Andreopoulou actively facilitates the interface between basic and applied research at the Meyer Cancer Center at Weill Cornell Medicine. She leads a multidisciplinary, prospective breast cancer biobank to provide a crucial foundation for precision medicine research. Dr Andreopoulou has also been active with breast cancer awareness programs covering screening and prevention with a particular focus in serving underserved minorities in the local area. She has published several peer-reviewed articles, reviews, editorials and book chapters. She is a member of the American Society of Clinical Oncology, the American Association of Cancer Research, the American Women`s Medical Association the Royal Society of Medicine in England, and the European Society of Medical Oncology.

Authored articles:

Oncology & Hematology Review (US)
Oncology & Hematology Review. 2018;14(1):16–17 DOI: https://doi.org/10.17925/OHR.2018.14.1.16